Richard J. Rodgers - Jan 3, 2022 Form 4 Insider Report for Ocuphire Pharma, Inc. (OCUP)

Role
Director
Signature
s/ Jeffrey Kuras, by Power of Attorney
Stock symbol
OCUP
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
4
Date filed
1/5/2022, 03:01 PM
Previous filing
Oct 4, 2021
Next filing
Apr 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUP Common Stock Award +4.02K +12.58% 36K Jan 3, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted common stock in lieu of cash for Q4 2021 Board services. The number of shares of Common Stock having an aggregate Fair Market Value equal to the aggregate amount of the Retainers for such fiscal quarter, determined by dividing (A) the aggregate amount of the Retainers by (B) the Fair Market Value of the Common Stock on last day of the fiscal quarter (rounded down to the nearest whole share). The Fair Market Value was $3.73 per share, the closing price of the Company's stock on December 31, 2021.